Skip to content
Govern the Executive-Company Boundary

When does executive content need regulatory or legal review?

By Joel Andren · Published by PressFriendly, a PR agency · Reviewed August 21, 2026 · Editorial standards · 5 of 5 in this section

Executive content needs regulatory or legal review before publication when it may disclose protected information, make a regulated claim, affect investors, create a legal position, commit the company, or increase litigation or enforcement risk. Put those triggers in writing. Routine, substantiated commentary can then move quickly, while the right specialist sees higher-risk claims in time to change them.

Potentially material or nonpublic information goes through disclosure controls

For a public company, route content about earnings, forecasts, operating metrics, financing, mergers, major customer activity, leadership changes, material incidents, and similar developments through the company's authorized disclosure process. Securities counsel or the disclosure owner should decide whether the information is material, public, and suitable for that channel.

A personal account does not create a safe exception. In 2024, the SEC charged DraftKings with violating Regulation FD after its public relations firm posted material nonpublic information on the CEO's personal X and LinkedIn accounts. DraftKings agreed to a $200,000 civil penalty and communications-related Regulation FD training.

The same trigger applies to a conference answer, podcast recording, repost, comment, or direct message. If the executive may be asked about unreleased results or a pending transaction, counsel should approve the boundaries and escalation contact before the appearance, not attempt to approve every sentence live.

Regulated claims need a subject-matter reviewer

Escalate claims about investments, financial products, health outcomes, prescription products, safety, environmental performance, government contracts, political activity, or licensed professional advice. The reviewer may be compliance, medical, scientific, regulatory, or local counsel rather than a general commercial lawyer.

Short formats do not make the underlying risk disappear. For example, FDA's current draft guidance on prescription-drug and medical-device promotion in character-limited social media says firms presenting benefit information should also present risk information in the communication. The guidance is nonbinding and applies to specified regulated firms and products, so use the relevant specialist to determine what governs the actual speaker, claim, product, and jurisdiction.

People, privacy, and active disputes need a separate risk path

Seek review before discussing investigations, terminations, allegations, pending litigation, confidential material, or identifiable customer, patient, or employee information. Confirm the authority to use testimonials, images, case studies, and personal data rather than treating factual accuracy as permission.

Employment responses deserve jurisdiction-specific review. The NLRB explains that online discussion of pay, benefits, and working conditions may be protected concerted activity. Protection depends on context, including a connection to group action, so a communications team should not improvise a takedown demand or disciplinary response.

The claim and risk determine who decides

Apply the three-party ownership test to every escalation:

  • Executive. Flags personal investments, relationships, prior statements, and tolerance for personal exposure. The executive decides whether to speak.
  • Payer and company. Fund necessary specialist review and set business risk limits. The relevant company fact owner confirms company information. Paying for a program does not transfer ownership of the executive's identity or personal account.
  • Manager and provider. Identify triggers, assemble support, route the question, revise the draft, and preserve the decision. They do not substitute their judgment for counsel, compliance, or the accountable fact owner.

If an executive self-funds the work but discusses company information, the company remains the risk owner for its confidential information and disclosure obligations. If the company funds the work, it still should not claim unrelated control over the executive's personal views.

Approval applies to one version, channel, and context

Send the reviewer the final draft, intended audience and destination, publication time, substantiation, relevant relationships, previous approvals, and one precise question. Set normal and urgent response times, name a backup reviewer, and record the approved version and conditions.

Re-review the work when a material claim, fact, disclosure, channel, or timing changes. Refresh the trigger matrix after a financing, transaction, investigation, new regulated product, executive role change, or enforcement development. Align it with executive-company decision rights and endorsement disclosures, then have qualified counsel adapt it to the governing jurisdictions.